Point72 Asset Management
ANAB icon

Point72 Asset Management’s AnaptysBio ANAB Stock Holding History

Point72 Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-55,303
Closed -$3.07M – 3970
2026
Q1 		$3.07M Sell
55,303
-1,877,587
-97% -$101M ﹤0.01% 2029
2025
Q4 		$93.7M Sell
1,932,890
-332,638
-15% -$13M 0.1% 199
2025
Q3 		$69.4M Sell
2,265,528
-209,346
-8% -$4.8M 0.12% 195
2025
Q2 		$54.9M Buy
2,474,874
+106,504
+4% +$2.23M 0.11% 231
2025
Q1 		$44M Buy
+2,368,370
New +$39.5M 0.1% 239
2024
Q4 		– Sell
-54,200
Closed -$1.82M – 2060
2024
Q3 		$1.82M Buy
54,200
+36,300
+203% +$1.24M ﹤0.01% 1230
2024
Q2 		$449K Sell
17,900
-846,200
-98% -$19.7M ﹤0.01% 1466
2024
Q1 		$19.5M Buy
864,100
+75,555
+10% +$1.79M 0.05% 461
2023
Q4 		$16.9M Sell
788,545
-2,655
-0.3% -$45.8K 0.04% 490
2023
Q3 		$14.2M Sell
791,200
-668,709
-46% -$12.8M 0.04% 517
2023
Q2 		$29.7M Sell
1,459,909
-221,238
-13% -$4.49M 0.09% 282
2023
Q1 		$36.6M Sell
1,681,147
-443,053
-21% -$10.8M 0.11% 220
2022
Q4 		$65.8M Sell
2,124,200
-402,000
-16% -$11.4M 0.22% 113
2022
Q3 		$64.4M Buy
2,526,200
+1,674,400
+197% +$39.2M 0.26% 99
2022
Q2 		$17.3M Sell
851,800
-465,800
-35% -$10.3M 0.07% 351
2022
Q1 		$32.6M Buy
1,317,600
+1,060,455
+412% +$32.1M 0.13% 211
2021
Q4 		$8.94M Buy
+257,145
New +$8.15M 0.04% 541
2021
Q1 		– Sell
-760,300
Closed -$16.3M – 944
2020
Q4 		$16.3M Buy
+760,300
New +$18.5M 0.08% 325
2020
Q3 		– Sell
-210,886
Closed -$4.71M – 910
2020
Q2 		$4.71M Buy
+210,886
New +$3.86M 0.03% 494
2020
Q1 		– Sell
-25,900
Closed -$421K – 766
2019
Q4 		$421K Buy
+25,900
New +$613K ﹤0.01% 788
2019
Q2 		– Sell
-33,600
Closed -$2.45M – 1321
2019
Q1 		$2.45M Buy
+33,600
New +$2.32M 0.01% 679

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Point72 Asset Management's ANAB Position: Q2 2026 in Review

Point72 Asset Management sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 55,303 shares — an estimated $3.07M sold.

Point72 Asset Management first reported a position in ANAB in Q1 2019 and held it in 21 quarters. The position peaked at $93.7M in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Point72 Asset Management reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 55,303 AnaptysBio shares in Q2 2026, an estimated $3.07M.
  • Point72 Asset Management first reported a position in AnaptysBio in Q1 2019 and held it in 21 quarters.
  • Point72 Asset Management's AnaptysBio position peaked at $93.7M in Q4 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.